News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
750,808 Results
Type
Article (44383)
Company Profile (468)
Press Release (705942)
Multimedia
Podcasts (149)
Webinars (23)
Section
Business (209607)
Career Advice (2052)
Deals (36259)
Drug Delivery (142)
Drug Development (84280)
Employer Resources (174)
FDA (16835)
Job Trends (15241)
News (354927)
Policy (33318)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (1)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (4)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (6)
Academia (2694)
Accelerated approval (58)
ADA (49)
Adcomms (33)
Allergies (196)
Alliances (51122)
ALS (233)
Alzheimer's disease (1895)
Antibody-drug conjugate (ADC) (533)
Approvals (17245)
Artificial intelligence (752)
ASCO (337)
Autoimmune disease (344)
Automation (60)
Bankruptcy (374)
Best Places to Work (11840)
BIOSECURE Act (20)
Biosimilars (234)
Biotechnology (325)
Bladder cancer (206)
Brain cancer (78)
Breast cancer (808)
Cancer (6391)
Cardiovascular disease (520)
Career advice (1748)
Career pathing (46)
CAR-T (365)
CDC (59)
Celiac Disease (3)
Cell therapy (994)
Cervical cancer (54)
Clinical research (73401)
Collaboration (2293)
Commercialization (1)
Company closure (5)
Compensation (1510)
Complete response letters (94)
COVID-19 (2818)
CRISPR (123)
C-suite (1261)
Cystic fibrosis (165)
Data (8681)
Decentralized trials (3)
Denatured (47)
Depression (183)
Dermatology (96)
Diabetes (670)
Diagnostics (7079)
Digital health (64)
Diversity (13)
Diversity, equity & inclusion (45)
Drug discovery (373)
Drug pricing (213)
Drug shortages (32)
Duchenne muscular dystrophy (316)
Earnings (93518)
Editorial (71)
Employer branding (21)
Employer resources (153)
Events (124364)
Executive appointments (1154)
FDA (20817)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (20)
Frontotemporal dementia (36)
Funding (1901)
Gene editing (263)
Generative AI (62)
Gene therapy (807)
GLP-1 (1142)
Government (4851)
Grass and pollen (6)
Guidances (416)
Healthcare (19488)
Hematology (194)
HIV (91)
Huntington's disease (63)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (114)
Immunology and inflammation (328)
Immuno-oncology (111)
Indications (213)
Infectious disease (3191)
Inflammatory bowel disease (231)
Inflation Reduction Act (17)
Influenza (144)
Intellectual property (319)
Interviews (321)
IPO (16969)
IRA (53)
Job creations (3721)
Job search strategy (1444)
JPM (67)
Kidney cancer (20)
Labor market (110)
Layoffs (608)
Leadership (43)
Legal (8032)
Liver cancer (105)
Longevity (35)
Lung cancer (846)
Lymphoma (476)
Machine learning (64)
Management (59)
Manufacturing (1152)
Marketing (1)
MASH (215)
Medical affairs (1)
Medical device (14137)
Medtech (14298)
Mergers & acquisitions (20587)
Metabolic disorders (1704)
mRNA (255)
Multiple sclerosis (201)
NASH (20)
Neurodegenerative disease (482)
Neuropsychiatric disorders (119)
Neuroscience (3586)
Neurotech (1)
NextGen: Class of 2026 (6775)
Non-profit (4615)
Now hiring (81)
Obesity (797)
Opinion (318)
Ovarian cancer (240)
Pain (271)
Pancreatic cancer (352)
Parkinson's disease (410)
Partnered (36)
Patents (634)
Patient recruitment (755)
Peanut (67)
People (61317)
Pharmaceutical (80)
Pharmacy benefit managers (34)
Phase 1 (23117)
Phase 2 (32392)
Phase 3 (23893)
Pipeline (9751)
Policy (344)
Postmarket research (2607)
Preclinical (9889)
Press Release (67)
Prostate cancer (343)
Psychedelics (67)
Radiopharmaceuticals (365)
Rare diseases (1224)
Real estate (6084)
Recruiting (71)
Regulatory (26266)
Reports (56)
Research institute (2521)
Resumes & cover letters (357)
Rett syndrome (42)
RNA editing (29)
RSV (90)
Schizophrenia (190)
Series A (325)
Series B (240)
Service/supplier (11)
Sickle cell disease (127)
Special edition (29)
Spinal muscular atrophy (172)
Sponsored (49)
Startups (3843)
State (2)
Stomach cancer (19)
Supply chain (138)
Tariffs (88)
The Weekly (99)
Vaccines (1173)
Venture capital (127)
Weight loss (519)
Women's health (139)
Worklife (21)
Date
Today (96)
Last 7 days (514)
Last 30 days (2734)
Last 365 days (31241)
2026 (15909)
2025 (31064)
2024 (36295)
2023 (41021)
2022 (52294)
2021 (56772)
2020 (54925)
2019 (47422)
2018 (35698)
2017 (33031)
2016 (32354)
2015 (38401)
2014 (32194)
2013 (27114)
2012 (29231)
2011 (29873)
2010 (28000)
Location
Africa (760)
Alabama (99)
Alaska (7)
Arizona (373)
Arkansas (16)
Asia (41415)
Australia (6895)
California (14138)
Canada (3944)
China (1523)
Colorado (606)
Connecticut (628)
Delaware (434)
Europe (91193)
Florida (2103)
Georgia (450)
Hawaii (3)
Idaho (63)
Illinois (1159)
India (97)
Indiana (632)
Iowa (26)
Japan (597)
Kansas (137)
Kentucky (53)
Louisiana (59)
Maine (76)
Maryland (1677)
Massachusetts (10256)
Michigan (379)
Minnesota (765)
Mississippi (6)
Missouri (149)
Montana (35)
Nebraska (30)
Nevada (148)
New Hampshire (89)
New Jersey (3712)
New Mexico (33)
New York (3678)
North Carolina (1839)
North Dakota (10)
Northern California (7111)
Ohio (422)
Oklahoma (23)
Oregon (44)
Pennsylvania (2791)
Puerto Rico (31)
Rhode Island (53)
South America (1126)
South Carolina (86)
South Dakota (2)
Southern California (5577)
Tennessee (225)
Texas (2256)
United States (50003)
Utah (418)
Vermont (2)
Virginia (348)
Washington D.C. (82)
Washington State (1153)
West Virginia (4)
Wisconsin (138)
Wyoming (2)
750,808 Results for "ascend therapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Seaport Therapeutics Reports Positive Multiple-Ascending Dose Data from Phase 1 Proof-of-Concept Trial of GlyphAgo™ in Healthy Volunteers
June 8, 2026
·
8 min read
Press Releases
Bambusa Therapeutics Presents Positive Preliminary Multiple Ascending Dose Phase 1 Data for BBT002 at the European Academy of Allergy & Clinical Immunology (EAACI) Annual Congress 2026
June 15, 2026
·
6 min read
Press Releases
Atisama Therapeutics Advances RB042 into Multiple Ascending Dose cohorts of Phase 1 Trial and Appoints Bernard Coulie as Chair of the Board
May 17, 2026
·
4 min read
Press Releases
PureTech Founded Entity Seaport Therapeutics Reports Positive Multiple-Ascending Dose Data from Phase 1 Proof-of-Concept Trial of GlyphAgo™ in Healthy Volunteers
June 9, 2026
·
12 min read
Press Releases
Definium Therapeutics Announces First Patient Dosed in Ascend, the Second Phase 3 Pivotal Study of DT120 ODT in Major Depressive Disorder
May 12, 2026
·
10 min read
Press Releases
Veritas Aortic Solutions, an inQB8 Spinout, Raises $12M to Advance Non-Surgical Treatment of Aortic Root and Ascending Aortic Diseases
June 1, 2026
·
5 min read
Press Releases
Bambusa Therapeutics Presented Positive Results from the Phase 1 Multiple Ascending Dose Trial of BBT001 at the 2026 American Academy of Dermatology (AAD) Annual Meeting
April 2, 2026
·
5 min read
Press Releases
SCYNEXIS Announces First Participants Dosed in a Phase 1 Single Ascending Dose and Multiple Ascending Dose Trial of Intravenous SCY-247
February 26, 2026
·
3 min read
Press Releases
Cue Biopharma Expands Pipeline with Exclusive License from Ascendant Health Sciences Ltd. for Clinical-Stage Dual-Mechanism Anti-IgE Antibody
April 30, 2026
·
9 min read
Press Releases
Crescent Biopharma Announces Trial in Progress Presentation for ASCEND Study of CR-001, a PD-1 x VEGF Bispecific Antibody, at Upcoming American Society of Clinical Oncology (ASCO) 2026 Annual Meeting
May 22, 2026
·
8 min read
1 of 75,081
Next
